Related Experiment Video
Updated: Jun 2, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Accelerated clinical discovery using self-reported patient data collected online and a patient-matching algorithm.
Paul Wicks1, Timothy E Vaughan, Michael P Massagli
1Research and Development, PatientsLikeMe Inc., Cambridge, Massachusetts, USA. pwicks@patientslikeme.com
Patients with amyotrophic lateral sclerosis (ALS) using lithium carbonate showed no disease progression difference. Online patient data can accelerate clinical discovery and drug evaluation.
Area of Science:
- Neurology
- Pharmacology
- Health Informatics
Background:
- Patients with serious diseases often experiment with unapproved drugs.
- Online patient communities offer a platform for monitoring drug usage and outcomes.
Purpose of the Study:
- To analyze the effectiveness of lithium carbonate in amyotrophic lateral sclerosis (ALS) patients using online data.
- To assess the utility of patient-reported outcomes for clinical discovery.
Main Methods:
- Analysis of data from PatientsLikeMe for ALS patients treated with lithium carbonate.
- Development of an algorithm to match treated patients with disease-matched controls to minimize bias.
Main Results:
- No significant effect of lithium carbonate on ALS disease progression was observed at 12 months.
- The study's findings aligned with subsequent randomized controlled trials.
Conclusions:
- Patient-reported data from online communities can be valuable for accelerating clinical discovery.
- Internet-based observational studies can aid in evaluating drug effectiveness, complementing traditional trials.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
06:32Bringing the Clinic Home: An At-Home Multi-Modal Data Collection Ecosystem to Support Adaptive Deep Brain Stimulation
Published on: July 14, 2023